These projects were made possible from Cure Alzheimer's Fund support.
Project Description | Researchers | Funding |
---|---|---|
SFRP1 as a Therapeutic Target and Diagnostic/Prognostic Factor in Alzheimer’s Disease |
2020, 2022 $345,000 |
These published papers resulted from Cure Alzheimer’s Fund support.
Pereyra, G., Mateo, M. I., Miaja, P., Martin-Bermejo, M. J., Martinez-Baños, M., Klaassen, R., Gruart, A., Rueda-Carrasco, J., Fernández-Rodrigo, A., López-Merino, E., Esteve, P., Esteban, J. A., Smit, A. B., Delgado-García, J. M., & Bovolenta, P. SFRP1 upregulation causes hippocampal synaptic dysfunction and memory impairment, Cell Reports, April 7, 2025, Read More